AS-604850
Cat. No.:YN420170
产品名称: | AS-604850 |
CAS No.: | 648449-76-7 |
Chemical Name: | 5-[(2,2-difluoro-1,3-benzodioxol-5-yl)methylene]-2,4-thiazolidinedione |
Synonyms: | 5-[(2,2-二氟-1,3-苯并二恶茂-5-基)亚甲基]噻唑烷-2,4-二酮 |
分子量: | 285.22 |
分子式: | C₁₁H₅F₂NO₄S |
SMILES: | O=C(NC/1=O)SC1=C\C2=CC=C(OC(F)(F)O3)C3=C2 |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | AS-604850 是一种有效的,具有选择性的和 ATP 竞争性的PI3Kγ抑制剂,IC50值为 0.25 μM,Ki值为 0.18 μM。AS-604850 是PI3Kγ的同工型选择性抑制剂,对PI3Kγ的选择性是 PI3Kδ/β 的 30 倍以上,是 PI3Kα 的 18 倍以上。 |
IC50和靶点: | [{name:"PI3Kγ:0.25 μM (IC50)"},{name: "PI3Kγ:0.18 μM (Ki)"},{name: "PI3Kα:4.5 μM (IC50)"}] |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Rameh, L.E., and Cantley, L.C.The role of phosphoinositide 3-kinase lipid products in cell functionJ. Biol. Chem.274(13),8347-8350(1999)
Vivanco, I., and Sawyers, C.L.The phosphatidylinositol 3-kinase-AKT pathway in human cancerNat. Rev. Cancer2(7),489-501(2002)
Hennessy, B.T., Smith, D.L., Ram, P.T., et al.Exploiting the PI3K/AKT pathway for cancer drug discoveryNat. Rev. Drug Discov.4(12),988-1004(2005)
Rückle, T., Schwarz, M.K., and Rommel, C.PI3Kγ inhibition: Towards an 'aspirin of the 21st century'?Nat. Rev. Drug Discov.5(11),903-918(2006)
Camps, M., Rückle, T., Ji, H., et al.Blockade of PI3K g suppresses joint inflammation and damage in mouse models of rheumatoid arthritisNat. Med.11(9),936-943(2005)